# Vanda Pharmaceuticals Inc.: Form 8-K, filed Apr 2, 2026

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 16:30 ET
- Period: 2026-03-29
- Accession: 0001628280-26-023222
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828026023222/vnda-20260329.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828026023222/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828026023222/vnda-20260329.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-023222. Last ingested by Listed: Nov 5, 2026, 17:59 ET. No prices; not investment advice.